Chemical Name: 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, sodium salt hydrate
Smiles: O=[S](C1=NC2=CC=CC=C2N1)CC(N=CC=C3OCCCOC)=C3C.O.[Na]
Inchi: InChI=1S/C19H21NOS/c1-20(2)12-10-18(16-11-13-22-14-16)21-19-9-5-7-15-6-3-4-8-17(15)19/h3-9,11,13-14,18H,10,12H2,1-2H3/t18-/m0/s1
Identification, isolation and characterization of new impurity in rabeprazole sodium
P. SreenivasaRao, Uttam KumarRay, P. BadarinadhGupta, D.V.N. SrinivasaRao, AminulIslam, PradeepRajput, K.Mukkanti
Journal of Pharmaceutical and Biomedical Analysis Volume 52, Issue 4, 1 August 2010, Pages 620-624
Development and validation of a stability indicating hplc method for the estimation of rabeprazole impurities in pharmaceutical dosage forms by design of experiments
T.v. raghava raju, s.raja kumar1, i.mrutyunjaya rao, n.someswara rao
Asian J Pharm Clin Res, Vol 6, Suppl4, 2013, 43-51
Identification and characterization of stressed degradation products of rabeprazole using LC-ESI/MS/MS and 1H-NMR experiments: in vitro toxicity evaluation of major degradation products
Murali Mohan Bhandi,a Roshan M. Borkar,a G. Shankar,a Snehal Raut,b Narayana Nageshc and R. Srinivas*
RSC Adv., 2016,6, 10719-10735
A Validated RP-HPLC Method for Simultaneous Quantification of Three Potential Genotoxic N-Oxides in Key Intermediate of Rabeprazole sodium
Karri Visweswara Rao1,2* , K Padmaja Reddy1 , Y Ravindra kumar1 , N Rajan
Journal of Pharmacy Research 2012,5(11),5206-5209